The Asthma Disease Market was valued at approximately USD 25 Billion in 2023 and is expected to grow at a strong CAGR of around ~5% during the forecast period (2024-2032) owing to the robust pipeline activity, advancements in genetic research, and patient-centered drug development. Asthma is characterized by inflammation of the airways evident by reversible airway obstruction and bronchospasm....